Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer. Matrone A, Prete A, Nervo A, Ragni A, et al. J Endocrinol Invest 2021 Feb 17. pii: 10.1007/s40618-020-01491.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Matrone A, Prete A, Nervo A, Ragni A, et al. Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer. J Endocrinol Invest 2021 Feb 17. pii: 10.1007/s40618-020-01491.
PMID: 33594641